Tepotinib
id:
tepotinib-281-7104313
title:
Tepotinib
text:
Tepotinib, sold under the brand name Tepmetko, is an anti-cancer medication used for the treatment of adults with non-small cell lung cancer (NSCLC). The most common side effects include edema, nausea, low albumin level in the blood, diarrhea, and increase in creatinine level in the blood. Tepotinib first received marketing approval in Japan, in March 2020, as a "line-agnostic" drug, meaning it is approved both for treatment-naive patients and for those in whom previous attempts at treatment hav
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Tepotinib
date created:
date modified:
2024-02-19T03:22:08Z
main entity:
{"identifier":"Q27088961","url":"https://www.wikidata.org/entity/Q27088961"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/b/b0/Tepotinib.svg","width":184,"height":131}
fields total:
13
integrity:
15